Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma
Titel:
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma
Auteur:
Esmaeli, B. McLaughlin, P. Pro, B. Samaniego, F. Gayed, I. Hagemeister, F. Romaguera, J. Cabanillas, F. Neelapu, S.S. Banay, R. Fayad, L. Wayne Saville, M. Kwak, L.W.